 | This article needs additional citations for verification. (June 2014) |
| Juvenile myelomonocytic leukemia | |
|---|---|
| Specialty | Oncology, hematology  |
| Usual onset | Under 4 years old[1] |
| Treatment | Stem cell transplant |
| Frequency | One to two children out of one million diagnosed each year[1] |
Juvenile myelomonocytic leukemia (JMML) is a rare form of chronic leukemia (cancer of the blood) that affects children, commonly those aged four and younger.[2] The name JMML now encompasses all diagnoses formerly referred to as juvenile chronic myeloid leukemia (JCML), chronic myelomonocytic leukemia of infancy, and infantile monosomy 7 syndrome. The average age of patients at diagnosis is two (2) years old.[2] The World Health Organization has included JMML as a subcategory of myelodysplastic and myeloproliferative disorders.
- ^ a b "Juvenile Myelomonocytic Leukemia". St. Jude Children's Research Hospital. Retrieved 2003-09-24.
- ^ a b Leukemia & Lymphoma Society. "Treatment". www.lls.org. Retrieved 2023-03-23.